Sarepta slumps as trial failure deepens woes for drugmaker - Reuters

Reuters | Nov. 4, 2025, 7:22 a.m. | Original
Sarepta slumps as trial failure deepens woes for drugmaker Reuters
Apollo beats Wall Street profit forecast on swelling assets, lending growth - Reuters Norwegian Cruise Line drops after missing Q3 revenue estimates - TradingView